Opdivo®

 
Active substance Nivolumab
Holder Bristol-Myers Squibb Belgium NV
Status Closed
Indication locally advanced and metastatic Non-Small-Cell Lung Cancer (NSCLC) in patients who have documented progression on or after prior chemotherapy
Public documents Approbation
Information for the patient
Informed consent
Last update 30/01/2017
Last updated on 13/09/2024